Abstract

• Interest in radiomics and machine learning is steadily increasing and is reflected both in research output and number of commercially available solutions.• Currently available commercial products using machine learning are often supported by limited evidence of clinical usefulness and studies are often of low methodological quality.• Ethical and regulatory issues remain open and hinder implementation of machine learning software packages in daily clinical practice.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call